标题
The Suitability of FGF21 and FGF23 as New Biomarkers in Endometrial Cancer Patients
作者
关键词
-
出版物
Diagnostics
Volume 10, Issue 6, Pages 414
出版商
MDPI AG
发表日期
2020-06-18
DOI
10.3390/diagnostics10060414
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Beyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communication
- (2019) Jan-Bernd Funcke et al. JOURNAL OF LIPID RESEARCH
- Association between Circulating Fibroblast Growth Factor 21 and Aggressiveness in Thyroid Cancer
- (2019) Yea Eun Kang et al. Cancers
- Global, Regional, and National Burden of Endometrial Cancer, 1990–2017: Results From the Global Burden of Disease Study, 2017
- (2019) Shuang Zhang et al. Frontiers in Oncology
- Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer
- (2018) Aneta Cymbaluk-Płoska et al. OncoTargets and Therapy
- Deficiency of fibroblast growth factor 21 (FGF21) promotes hepatocellular carcinoma (HCC) in mice on a long term obesogenic diet
- (2018) Garima Singhal et al. Molecular Metabolism
- Association between resistin and fibroblast growth factor 23 in patients with type 2 diabetes mellitus
- (2018) Akio Nakashima et al. Scientific Reports
- Alteration in serum concentrations of FGF19, FGF21, and FGF23 in patients with urothelial carcinoma
- (2018) Jian-Ri Li et al. BIOFACTORS
- Fibroblast growth factor 21 as a circulating biomarker at various stages of colorectal carcinogenesis
- (2018) Jing Qian et al. BRITISH JOURNAL OF CANCER
- Association Between Plasma Concentration of Klotho Protein, Osteocalcin, Leptin, Adiponectin, and Bone Mineral Density in Patients with Chronic Kidney Disease
- (2018) Małgorzata Marchelek-Mysliwiec et al. HORMONE AND METABOLIC RESEARCH
- Endometrial Cancers Harboring Mutated Fibroblast Growth Factor Receptor 2 Protein Are Successfully Treated With a New Small Tyrosine Kinase Inhibitor in an Orthotopic Mouse Model
- (2017) Sebastien Taurin et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach
- (2017) Marco Presta et al. PHARMACOLOGY & THERAPEUTICS
- Correlation analysis between the expressions of leptin and its receptor (ObR) and clinicopathology in endometrial cancer
- (2017) Yun Zhang et al. Cancer Biomarkers
- Renaissance of leptin for obesity therapy
- (2016) Carmelo Quarta et al. DIABETOLOGIA
- Expression and localization of fibroblast growth factor (FGF)23 and Klotho in the spleen: its physiological and functional implications
- (2016) Yuri Nakashima et al. GROWTH FACTORS
- Plasma Leptin Levels and Risk of Incident Cancer: Results from the Dallas Heart Study
- (2016) Arjun Gupta et al. PLoS One
- Antitumor effects and molecular mechanisms of ponatinib on endometrial cancer cells harboring activating FGFR2 mutations
- (2015) Do-Hee Kim et al. CANCER BIOLOGY & THERAPY
- FGF23 promotes prostate cancer progression
- (2015) Shu Feng et al. Oncotarget
- Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress
- (2013) Chaofeng Yang et al. BMC GASTROENTEROLOGY
- Combined targeting of FGFR2 and mTOR by ponatinib and ridaforolimus results in synergistic antitumor activity in FGFR2 mutant endometrial cancer models
- (2013) Joseph M. Gozgit et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Fibroblast Growth Factor Receptor Inhibitors as a Cancer Treatment: From a Biologic Rationale to Medical Perspectives
- (2013) Maria Vittoria Dieci et al. Cancer Discovery
- The association of FGF23 levels in obese adolescents with insulin sensitivity
- (2012) Malgorzata Wojcik et al. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
- Control of lipid metabolism by adipocyte FGFR1-mediated adipohepatic communication during hepatic stress
- (2012) Chaofeng Yang et al. Nutrition & Metabolism
- Targeting Fibroblast Growth Factor Receptors Blocks PI3K/AKT Signaling, Induces Apoptosis, and Impairs Mammary Tumor Outgrowth and Metastasis
- (2010) J. H. Dey et al. CANCER RESEARCH
- Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
- (2010) f. M. Fisher et al. DIABETES
- FGF21 signalling pathway and metabolic traits – genetic association analysis
- (2010) Bernhard M Kaess et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- The FGF family: biology, pathophysiology and therapy
- (2009) Andrew Beenken et al. NATURE REVIEWS DRUG DISCOVERY
- Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells
- (2008) Jingchun Gao et al. CANCER SCIENCE
- The Klotho gene family as a regulator of endocrine fibroblast growth factors
- (2008) Hiroshi Kurosu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Adipose Fibroblast Growth Factor 21 Is Up-Regulated by Peroxisome Proliferator-Activated Receptor and Altered Metabolic States
- (2008) E. S. Muise et al. MOLECULAR PHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started